Predictive Oncology Inc.
POAI
$1.06
-$0.03-2.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 37.57% | -- | 18.91% | -23.29% | 56.10% |
| Total Depreciation and Amortization | 10.75% | -- | -8.83% | -31.65% | 55.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -106.38% | -- | -48.00% | -101.48% | -93.99% |
| Change in Net Operating Assets | -56.31% | -- | -427.84% | 342.43% | -149.46% |
| Cash from Operations | 30.30% | -- | 9.97% | 0.34% | 4.72% |
| Capital Expenditure | -100.00% | -- | 97.45% | 87.70% | 126.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -46.43% |
| Cash from Investing | -100.00% | -- | 97.49% | 93.56% | 111.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -78.32% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 93.64% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -75.92% | -- | -- | -- | -371.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.43% | -- | 103.51% | -1.64% | 4.09% |